Biogen Inc.

US$248.35As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BIIBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (0.38%)
Div yield —
ROE 1.87%
Drug Manufacturers (General)
Beta (5Y) 0.09
PE TTM 106.3
TSR TTM 60.98%
Mkt cap US$36.71B
ROIC 7.36%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$272
9.58%
(49.58%)
Hold 9|9|1|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.36
2.27
2.40
2.32
10.18%
0.69%
(0.23%)
(2.93%)
Revenue$B
1.921
1.979
1.978
1.993
2.09%
5.97%
1.22%
2.73%
Peers (US$36.71B)
Cap (US$)
PE
167.5B
41.88x
38.54B
15.74x
Capital
TTM
5Y
10Y
Leveragex
0.402
0.012
0.011
EBIT/Intx
0.270
0.175
0.163
Own earn%
(75.23)
(109.01)
(101.17)
Sh yield%
36.81
21.56
19.20
Owners
Insiders/Inst%
6.85
76.30
Short interest%
2.97
SBC / revenue%
5.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
11–20
$1 testx
0.7
Incr. ROIC%
9